Association between serum lithium level and incidence of COVID-19 infection. Association entre les niveau de lithium et l'incidence de l'infection à la Covid-19

Archive ouverte

de Picker, Livia | Leboyer, Marion | Geddes, John | Morrens, Manuel | Harrison, Paul | Taquet, Maxime

Edité par CCSD ; Royal College of Psychiatrists -

International audience. An antiviral effect of lithium has been proposed, but never investigated for COVID-19. Using electronic health records of 26,554 patients with documented serum lithium levels during the pandemic, we show that the 6-month COVID-19 infection incidence was lower among matched patients with 'therapeutic' (0.50-1.00) vs. 'sub-therapeutic' (0.05-0.50) lithium levels (HR 0.82, 95% CI 0.69-0.97, p=0.017) and among matched patients with 'therapeutic' lithium levels vs. patients using valproate (HR 0.79, 95% CI 0.67-0.92, p=0.0023). Lower rates of infection were observed for both new COVID-19 diagnoses and positive PCR tests, regardless of underlying psychiatric diagnosis and vaccination status.

Suggestions

Du même auteur

Executive Committee Global Summit on Precision Psychiatry

Archive ouverte | Leboyer, Marion | CCSD

Policy brief following the global summit for Precision Psychiatry held in Brussels in may 2024. International audience

Patients with psychosis spectrum disorders hospitalized during the COVID-19 pandemic unravel overlooked SARS-CoV-2 past infection clustering with HERV-W ENV expression and chronic inflammation

Archive ouverte | Tamouza, Ryad | CCSD

International audience. Epidemiology has repeatedly associated certain infections with a risk of further developing psychiatric diseases. Such infections can activate retro-transposable genetic elements (HERV) known...

Advancing precision psychiatry and targeted treatments: Insights from immunopsychiatry

Archive ouverte | Miller, Andrew | CCSD

International audience. Despite tremendous advancements in neuroscience, there has been limited impact on patient care. Current psychiatric treatments are largely non-specific, and drug development is hindered by ou...

Chargement des enrichissements...